As of 30 Sep 2025, 2 institutional investors reported holding 801 shares of Predictive Oncology Inc. - COM (POAI).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 801 | $9,921 | -$279,211 | $7.54 | 2 |
| 2025 Q2 | 181,793 | $150,424 | -$16,235 | $0.83 | 11 |
| 2025 Q1 | 184,595 | $280,598 | -$24,274 | $1.52 | 13 |
| 2024 Q4 | 240,735 | $197,407 | +$32,505 | $0.82 | 15 |
| 2024 Q3 | 201,860 | $156,813 | -$94,318 | $0.79 | 14 |
| 2024 Q2 | 288,551 | $299,897 | -$244,714 | $1.04 | 16 |
| 2024 Q1 | 348,143 | $887,987 | -$63,874 | $2.55 | 13 |
| 2023 Q4 | 367,110 | $1,208,179 | -$4,168 | $3.29 | 16 |
| 2023 Q3 | 368,692 | $1,179,838 | +$438,112 | $3.20 | 15 |
| 2023 Q2 | 231,783 | $1,126,727 | +$1,126,727 | $4.86 | 11 |